Abstract
Five hundred thirty-seven patients were enrolled in two independent, investigator-blinded, multicenter, randomized clinical trials comparing the clinical and bacteriologic efficacies and the safety of 5- or 10-day treatment with cefuroxime axetil with those of 10-day treatment with amoxicillin-clavulanate in the treatment of secondary bacterial infections of acute bronchitis. Patients received either 5 or 10 days of treatment (n = 177 in each group) with cefuroxime axetil at 250 mg twice daily or 10 days of treatment (n = 183) with amoxicillin-clavulanate at 500 mg three times daily. Patients in the cefuroxime axetil (5 days) group received placebo on days 6 to 10. Bacteriologic assessments were based on sputum specimen cultures obtained preceding and, when possible, following treatment. Organisms were isolated from the pretreatment sputum specimens of 242 of 537 (45%) patients, with the primary pathogens being Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Streptococcus pneumoniae, and Staphylococcus aureus (28, 25, 13, 9, and 8% of isolates, respectively). Pathogens were eradicated or presumed to be eradicated in 87% (52 of 60), 91% (53 of 58), and 86% (60 of 70) of bacteriologically evaluable pati...Continue Reading
References
Sep 1, 1992·The American Journal of Medicine·A E CamachoJ J Collins
Jan 1, 1991·Diagnostic Microbiology and Infectious Disease·G V Doern
Mar 1, 1991·The Journal of Antimicrobial Chemotherapy·A G ArguedasM I Marks
Dec 1, 1990·The Journal of Antimicrobial Chemotherapy·H PortierF Guetat
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·J H JorgensenJ S Redding
Jul 1, 1990·Diagnostic Microbiology and Infectious Disease·G V Doern, T A Tubert
Feb 1, 1990·Drugs·P A Todd, P Benfield
Oct 1, 1990·Southern Medical Journal·M PichicheroP M Darden
Aug 1, 1988·The Journal of Antimicrobial Chemotherapy·A M Emmerson
Jan 1, 1988·Scandinavian Journal of Infectious Diseases·A StrömbergO Cars
Jan 1, 1988·The Pediatric Infectious Disease Journal·W A HendrickseJ D Nelson
Feb 1, 1988·Archives of Internal Medicine·C J SchleupnerB Vogelman
Jan 1, 1988·Antimicrobial Agents and Chemotherapy·C C Knapp, J A Washington
Nov 1, 1987·Biopharmaceutics & Drug Disposition·A FinnJ Chubb
Mar 1, 1987·The Journal of Antimicrobial Chemotherapy·F P MaesenC Baur
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·S M HardingJ Ayrton
Feb 1, 1984·The Journal of Antimicrobial Chemotherapy·P E Williams, S M Harding
Oct 1, 1994·Archives of Pediatrics & Adolescent Medicine·M E PichicheroJ M Musser
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·H PortierC Safran
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·S E McLinnM J Ossi
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·J A WashingtonC C Knapp
Mar 1, 1993·Diagnostic Microbiology and Infectious Disease·P R MurrayE H Gerlach
Citations
Jul 1, 1996·Clinical Therapeutics·M J SperlingK J Tack
Dec 12, 2001·International Journal of Antimicrobial Agents·R G Masterton, C J Burley
Aug 13, 1998·The Journal of Antimicrobial Chemotherapy·T Shinohara, T Briski
Feb 24, 2001·Clinical Therapeutics·M H GotfriedW N Sokol
Dec 1, 2001·Clinical Therapeutics·E M PerfettoJ Li-McLeod
Jul 31, 2008·Journal of Enzyme Inhibition and Medicinal Chemistry·Ozen OzensoyFeray Kockar
Jan 24, 2006·Chest·Sidney S Braman
Jul 5, 2005·The American Journal of Medicine·Thomas G SlamaUNKNOWN Council for Appropriate and Rational Antibiotic Therapy (CARAT)
Oct 28, 2016·PloS One·Ji Young ParkYong Il Hwang
Jun 20, 2017·The Cochrane Database of Systematic Reviews·Susan M SmithLorne A Becker
Feb 4, 1998·Antimicrobial Agents and Chemotherapy·S ChodoshS Breisch
Sep 18, 2001·Drugs·L J ScottK L Goa
Jun 17, 2020·Journal of Biomolecular Structure & Dynamics·Ashimiyu B DurojaiyeCan Wang
Apr 15, 2021·International Journal of Antimicrobial Agents·Felix CheyssonLaurence Watier